BioSET® is leading an orthobiologic revolution…a step beyond growth factors. By pairing biomimetic growth factors with biomaterial scaffolds, BioSET is redefining surgical grafting and tissue regeneration.

These combination products represent the next step in tissue regeneration technology, offering surgeons and their patients new and powerful tools for repairing damaged or diseased tissue in musculoskeletal surgery.

New Markets Team Members:

Mark Grovic

Co-Founder and General Partner




BioSET Announces Initiation of Clinical Trials for AMPLEX Osteo-Promotive Bone Graft System for Spine Fusion
Pilot Studies Initiated in both the U.S. and Canada, and...

Join our Mailing list!

Get all the latest news and updates.